InsiderTrades.com logo
The A.I. story nobody is telling you (Read ASAP)
From TradeSmith   |   Ad
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
Click here to see Louis' new video for yourself.

GTBP Insider Trading

Insider Ownership Percentage: 10.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

GT Biopharma Insider Trading History Chart

This chart shows the insider buying and selling history at GT Biopharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

GT Biopharma Share Price & Price History

Current Price: $3.79
Price Change: ▲ Price Increase of +0.14 (3.84%)
As of 04/25/2024 02:31 PM ET

This chart shows the closing price history over time for GTBP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
This Apple-like Innovator is Revolutionizing Healthcare
From Wall Street Star   |   Ad
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Click here to learn more about the booming eHealth industry

GT Biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/11/2023Michael Martin BreenCEOBuy1,666$15.00$24,990.0021,873View SEC Filing Icon  
4/6/2023Manu OhriCFOBuy1,666$15.00$24,990.001,666View SEC Filing Icon  
See Full Table
This Apple-like Innovator is Revolutionizing Healthcare
From Wall Street Star   |   Ad
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Click here to learn more about the booming eHealth industry

SEC Filings (Institutional Ownership Changes) for GT Biopharma (NASDAQ:GTBP)

8.15% of GT Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GTBP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

GT Biopharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/2/2023Bank of Montreal Can596,240$0.26M0.0%N/A1.596%Search for SEC Filing on Google Icon
1/23/2023Baskin Financial Services Inc.151,354$0.13M0.0%N/A0.466%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC24,864$44K0.0%N/A0.076%Search for SEC Filing on Google Icon
5/5/2022Russell Investments Group Ltd.11,007$31K0.0%N/A0.033%Search for SEC Filing on Google Icon
5/2/2022Allspring Global Investments Holdings LLC25,782$74K0.0%N/A0.078%Search for SEC Filing on Google Icon
4/20/2022Sigma Planning Corp21,400$62K0.0%N/A0.067%Search for SEC Filing on Google Icon
2/14/2022Gordian Capital Singapore Pte Ltd35,000$0.11M0.1%N/A0.114%Search for SEC Filing on Google Icon
2/9/2022Compagnie Lombard Odier SCmA30,000$92K0.0%+100.0%0.098%Search for SEC Filing on Google Icon
2/4/2022Crumly & Associates Inc.32,163$85K0.0%N/A0.105%Search for SEC Filing on Google Icon
2/3/2022Brighton Jones LLC11,288$34K0.0%N/A0.037%Search for SEC Filing on Google Icon
1/31/2022Commonwealth Equity Services LLC11,052$33K0.0%N/A0.036%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP51,100$0.34M0.0%+243.0%0.242%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP162,823$1.10M0.0%N/A0.771%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP16,577$0.11M0.0%-35.7%0.078%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.28,500$0.19M0.0%N/A0.135%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC84,700$0.57M0.0%N/A0.401%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC424,279$2.86M0.0%+22.4%2.008%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.52,426$0.35M0.0%N/A0.248%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.1,155,228$7.79M0.0%-18.3%5.468%Search for SEC Filing on Google Icon
11/8/2021State Board of Administration of Florida Retirement System18,224$0.12M0.0%N/A0.086%Search for SEC Filing on Google Icon
11/8/2021Russell Investments Group Ltd.9,642$64K0.0%N/A0.046%Search for SEC Filing on Google Icon
11/5/2021Welch Group LLC10,000$67K0.0%N/A0.047%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG11,400$77K0.0%-25.7%0.054%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund8,230$55K0.0%-59.7%0.039%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP25,792$0.40M0.0%N/A0.122%Search for SEC Filing on Google Icon
8/17/2021Metropolitan Life Insurance Co NY8,782$0.14M0.0%N/A0.042%Search for SEC Filing on Google Icon
8/17/2021MetLife Investment Management LLC11,471$0.18M0.0%N/A0.054%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC510,058$7.91M0.0%N/A2.414%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System32,878$0.51M0.0%N/A0.156%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.57,993$0.90M0.0%N/A0.274%Search for SEC Filing on Google Icon
8/16/2021State Street Corp374,704$5.81M0.0%N/A1.773%Search for SEC Filing on Google Icon
8/16/2021Nuveen Asset Management LLC82,151$1.27M0.0%N/A0.389%Search for SEC Filing on Google Icon
8/16/2021Marshall Wace LLP25,792$0.40M0.0%N/A0.122%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp225,457$3.50M0.0%+555.6%1.067%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC346,606$5.37M0.0%+165.8%1.641%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.982,269$15.23M0.0%+267.0%4.649%Search for SEC Filing on Google Icon
8/12/2021Legal & General Group Plc2,524$39K0.0%N/A0.012%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.9,155$0.14M0.0%N/A0.043%Search for SEC Filing on Google Icon
8/12/2021The Manufacturers Life Insurance Company13,758$0.21M0.0%N/A0.065%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp58,711$0.91M0.0%N/A0.278%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.1,413,391$21.91M0.0%N/A6.690%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG15,349$0.24M0.0%N/A0.073%Search for SEC Filing on Google Icon
8/10/2021Citigroup Inc.6,134$95K0.0%N/A0.029%Search for SEC Filing on Google Icon
8/6/2021Ameritas Investment Partners Inc.1,870$29K0.0%N/A0.009%Search for SEC Filing on Google Icon
8/5/2021Rhumbline Advisers18,634$0.29M0.0%N/A0.088%Search for SEC Filing on Google Icon
8/2/2021New York State Common Retirement Fund20,400$0.32M0.0%N/A0.097%Search for SEC Filing on Google Icon
8/2/2021Advisor Group Holdings Inc.2,943$45K0.0%+108.3%0.014%Search for SEC Filing on Google Icon
7/31/2021Davy Global Fund Management Ltd35,113$0.54M0.1%+33.4%0.166%Search for SEC Filing on Google Icon
7/15/2021Compagnie Lombard Odier SCmA15,000$0.23M0.0%N/A0.071%Search for SEC Filing on Google Icon
7/6/2021Silverleafe Capital Partners LLC104,000$1.61M0.6%N/A0.492%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC22,741$0.16M0.0%N/A0.080%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC16,543$0.11M0.0%N/A0.058%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC27,895$0.19M0.0%N/A0.098%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada24,542$0.17M0.0%N/A0.086%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp34,387$0.24M0.0%N/A0.121%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC130,388$0.89M0.0%N/A0.459%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG3,918$27K0.0%N/A0.014%Search for SEC Filing on Google Icon
5/11/2021Davy Global Fund Management Ltd26,321$0.18M0.0%N/A0.093%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
GT Biopharma logo
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I clinical trial for the treatment of myelodysplastic syndromes, refractory/relapsed acute myeloid leukemia or advanced systemic mastocytosis, and CD33+ malignancies. The company is developing GTB-3650, which is in preclinical studies that target CD33 on the surface of myeloid leukemias; and GTB-5550 that is in preclinical studies for treating patients with B7-H3 positive solid tumors. GT Biopharma, Inc. has a co-development partnership agreement with Altor BioScience Corporation for the clinical development of a 161533 TriKE fusion protein for cancer therapies; and a license agreement with the Regents of the University of Minnesota to develop and commercialize cancer therapies using TriKE technology. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in Brisbane, California.
Read More on GT Biopharma

Today's Range

Now: $3.79
Low: $3.55
High: $3.88

50 Day Range

MA: $4.23
Low: $3.54
High: $5.07

52 Week Range

Now: $3.79
Low: $3.52
High: $16.11

Volume

3,203 shs

Average Volume

11,699 shs

Market Capitalization

$5.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.59

Who are the company insiders with the largest holdings of GT Biopharma?

GT Biopharma's top insider investors include:
  1. Michael Martin Breen (CEO)
  2. Manu Ohri (CFO)
Learn More about top insider investors at GT Biopharma.
The A.I. story nobody is telling you (Read ASAP)
From TradeSmith   |   Ad
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
Click here to see Louis' new video for yourself.